Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Morten Rühwald"'
Autor:
Chacha Mangu, Marta Cossa, Robert Ndege, Celso Khosa, Vinzeigh Leukes, Laura de la Torre-Pérez, Antonio Machiana, Bernard Kivuma, Dorcas Mnzava, Craysophy Zachariah, Patricia Manjate, Elisa Tagliani, Claudia Schacht, Julia Buech, Sunita Singh, Joanna Ehrlich, Friedrich Riess, Sergi Sanz, Katharina Kranzer, Helen Cox, Issa Sabi, Dinis Nguenha, Bindiya Meggi, Maja Weisser, Nyanda Ntinginya, Samuel Schumacher, Morten Ruhwald, Adam Penn-Nicholson, Alberto L. Garcia-Basteiro, TB-CAPT Consortium
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Introduction Tuberculosis (TB) is an important cause of morbidity and mortality among people living with HIV (PLHIV). Current WHO-recommended strategies for diagnosing TB among hospitalized PLHIV rely on symptom screening and disease severit
Externí odkaz:
https://doaj.org/article/e8ff71986d5249bd86e48add2cf630d4
Autor:
Colin A Russell, Morten Ruhwald, Brooke E Nichols, Shaukat Khan, Tom Ockhuisen, Alexandra de Nooy, Helen E Jenkins, Alvin Han, Sarah Girdwood, Mikashmi Kohli
Publikováno v:
BMJ Public Health, Vol 2, Iss 1 (2024)
The objective of this scoping review is to understand the cost-effectiveness of current and future tools/strategies for screening and diagnosis of tuberculosis (TB) infection and disease. To this end, PubMed, EMBASE and SCOPUS were used to identify a
Externí odkaz:
https://doaj.org/article/4d4fa88b14444dc99a4396d857a59495
Autor:
Nguyen B Hoa, Mark Fajans, Hung Nguyen Van, Bao Vu Ngoc, Nhung Nguyen Viet, Hoa Nguyen Thi, Lien Tran Thi Huong, Dung Tran Minh, Cuong Nguyen Kim, Trinh Ha Thi Tuyet, Tri Nguyen Huu, Diep Bui Ngoc, Hai Nguyen Viet, An Tran Khanh, Lorraine Lillis, Marcos Perez, Katherine K Thomas, Roger B Peck, Jason L Cantera, Eileen Murphy, Olivia R Halas, Helen L Storey, Abraham Pinter, Morten Ruhwald, Paul K Drain, David S Boyle
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 11, p e0003891 (2024)
Lipoarabinomannan (LAM) is a promising target biomarker for diagnosing subclinical and clinical tuberculosis (TB). Urine LAM (uLAM) testing using rapid diagnostic tests (RDTs) has been approved for people living with HIV (PLWH), however there is limi
Externí odkaz:
https://doaj.org/article/166403e595db4f38a8a7f2969d664e6c
Autor:
Rita Székely, Bianca Sossen, Madalo Mukoka, Monde Muyoyeta, Elizabeth Nakabugo, Jerry Hella, Hung Van Nguyen, Sasiwimol Ubolyam, Kinuyo Chikamatsu, Aurélien Macé, Marcia Vermeulen, Chad M Centner, Sarah Nyangu, Nsala Sanjase, Mohamed Sasamalo, Huong Thi Dinh, The Anh Ngo, Weerawat Manosuthi, Supunnee Jirajariyavej, Satoshi Mitarai, Nhung Viet Nguyen, Anchalee Avihingsanon, Klaus Reither, Lydia Nakiyingi, Andrew D Kerkhoff, Peter MacPherson, Graeme Meintjes, Claudia M Denkinger, Morten Ruhwald, FujiLAM Study Consortium
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303846 (2024)
There is an urgent need for rapid, non-sputum point-of-care diagnostics to detect tuberculosis. This prospective trial in seven high tuberculosis burden countries evaluated the diagnostic accuracy of the point-of-care urine-based lipoarabinomannan as
Externí odkaz:
https://doaj.org/article/dd9edaf5a71443d98a7f709229eb4479
Autor:
E Chandler Church, MD, Karen R Steingart, MD, Gerard A Cangelosi, ProfPhD, Morten Ruhwald, MD, Mikashmi Kohli, PhD, Adrienne E Shapiro, MD
Publikováno v:
The Lancet Global Health, Vol 12, Iss 1, Pp e45-e54 (2024)
Summary: Background: Tuberculosis is a leading cause of infectious disease mortality worldwide, but diagnosis of pulmonary tuberculosis remains challenging. Oral swabs are a promising non-sputum alternative sample type for the diagnosis of pulmonary
Externí odkaz:
https://doaj.org/article/87e2f9b071474a9cb01944a523ed3729
Autor:
Sophia B. Georghiou, Margaretha de Vos, Kavindhran Velen, Paolo Miotto, Rebecca E. Colman, Daniela Maria Cirillo, Nazir Ismail, Timothy C. Rodwell, Anita Suresh, Morten Ruhwald
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTDiagnostic development must occur in parallel with drug development to ensure the longevity of new treatment compounds. Despite an increasing number of novel and repurposed anti-tuberculosis compounds and regimens, there remains a large numbe
Externí odkaz:
https://doaj.org/article/b0643a8ee9614a38b1758f391701c6ea
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/04ff6284c31c4232b6bd8da345f3ca50
Autor:
Gideon Nsubuga, Samuel Kennedy, Yasha Rani, Zibran Hafiz, Soyeon Kim, Morten Ruhwald, David Alland, Jerrold Ellner, Moses Joloba, Susan E. Dorman, Adam Penn-Nicholson, Lydia Nakiyingi
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 31, Iss , Pp 100362- (2023)
Background: The NOVA Tuberculosis Total Antibody Rapid Test is a commercially available lateral flow serological assay that is intended to be used as an aid in the diagnosis of tuberculosis. We conducted a study to estimate diagnostic accuracy of thi
Externí odkaz:
https://doaj.org/article/2e1218e8ee2546c99f669e0b2aadd7b1
Autor:
Emily Lai-Ho MacLean, Paolo Miotto, Lice González Angulo, Matteo Chiacchiaretta, Timothy M Walker, Martina Casenghi, Camilla Rodrigues, Timothy C Rodwell, Philip Supply, Emmanuel André, Mikashmi Kohli, Morten Ruhwald, Daniela Maria Cirillo, Nazir Ismail, Matteo Zignol
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 3, p e0001754 (2023)
There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accu
Externí odkaz:
https://doaj.org/article/f2e3ac4950664f398da740532ca77b52
Autor:
Niklaus D. Labhardt, Lucia González Fernández, Bulemba Katende, Josephine Muhairwe, Moniek Bresser, Alain Amstutz, Tracy R. Glass, Morten Ruhwald, Jilian A. Sacks, Camille Escadafal, Mathabo Mareka, Sekhele M. Mooko, Margaretha de Vos, Klaus Reither
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Objectives To assess the real-world diagnostic performance of nasal and nasopharyngeal swabs for SD Biosensor STANDARD Q COVID-19 Antigen Rapid Diagnostic Test (Ag-RDT). Methods Individuals ≥5 years with COVID-19 compatible symptoms or history of e
Externí odkaz:
https://doaj.org/article/d70ed45cac254922a0f093a738b0b6e6